BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22019184)

  • 41. [Acute bacterial cystitis].
    Botto H
    Rev Prat; 2002 Jan; 52(1):23-7. PubMed ID: 11852760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility.
    Koeijers JJ; Verbon A; Kessels AG; Bartelds A; Donkers G; Nys S; Stobberingh EE
    Urology; 2010 Aug; 76(2):336-40. PubMed ID: 20494416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles.
    Wagenlehner FM; Naber KG
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):923-31. PubMed ID: 15566335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
    Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistenze antibiotiche e nuove molecole: qual è lo scenario attuale? .
    Novelli A
    Urologia; 2018 Jul; 85(1_suppl):S5-S13. PubMed ID: 30081777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of bacterial urinary tract infections: presence and future.
    Wagenlehner FM; Naber KG
    Eur Urol; 2006 Feb; 49(2):235-44. PubMed ID: 16413668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sultamicillin in treatment of genito-urinary infections].
    Dutkiewicz S
    Pol Tyg Lek; 1993 Oct; 48 Suppl 2():16-7. PubMed ID: 8008661
    [No Abstract]   [Full Text] [Related]  

  • 50. Emerging drugs for bacterial urinary tract infections.
    Wagenlehner FM; Weidner W; Naber KG
    Expert Opin Emerg Drugs; 2005 May; 10(2):275-98. PubMed ID: 15934867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antimicrobial susceptibility of organisms infecting the urinary tract in northern Israel].
    Oren B; Raz R; Hefter H; Kennes Y; Potasman I
    Harefuah; 1991 Jan; 120(2):60-2. PubMed ID: 2007488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary tract infection: traditional pharmacologic therapies.
    Nicolle LE
    Dis Mon; 2003 Feb; 49(2):111-28. PubMed ID: 12601341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-infective treatment of bacterial urinary tract infections.
    Wagenlehner FM; Pilatz A; Naber KG; Perletti G; Wagenlehner CM; Weidner W
    Curr Med Chem; 2008; 15(14):1412-27. PubMed ID: 18537619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections?].
    Naber KG; Alidjanov JF
    Urologiia; 2016 Aug; (3 Suppl 3):37-44. PubMed ID: 28247617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Guideline-based treatment of urinary tract infections].
    Ternes B; Wagenlehner FME
    Urologe A; 2020 May; 59(5):550-558. PubMed ID: 32240318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria.
    Dewar S; Reed LC; Koerner RJ
    J Antimicrob Chemother; 2014 Feb; 69(2):303-8. PubMed ID: 24068280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uncomplicated urinary tract infections.
    Wagenlehner FM; Hoyme U; Kaase M; Fünfstück R; Naber KG; Schmiemann G
    Dtsch Arztebl Int; 2011 Jun; 108(24):415-23. PubMed ID: 21776311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uncomplicated Bacterial Community-Acquired Urinary Tract Infection in Adults.
    Kranz J; Schmidt S; Lebert C; Schneidewind L; Schmiemann G; Wagenlehner F
    Dtsch Arztebl Int; 2017 Dec; 114(50):866-873. PubMed ID: 29271346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Rationale for the choice of an antibiotic for urinary tract infections with an emphasis on the environmental safety of therapy].
    Yakovlev SV; Suvorova MP
    Urologiia; 2021 Sep; (4):97-105. PubMed ID: 34486282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trattamento antibiotico empirico, mirato o ragionato? Dalla pratica clinica alle Linee Guida EAU 2017.
    Cai T
    Urologia; 2018 Jul; 85(1_suppl):S14-S19. PubMed ID: 30081779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.